Related Experiment Video
Updated: Jan 31, 2026
Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Marcus Ruscetti1, Josef Leibold1, Matthew J Bott1
1Department of Cancer Biology and Genetics, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Abstract:
Molecularly targeted therapies aim to obstruct cell autonomous programs required for tumor growth. We show that mitogen-activated protein kinase (MAPK) and cyclin-dependent kinase 4/6 inhibitors act in combination to suppress the proliferation of KRAS-mutant lung cancer cells while simultaneously provoking a natural killer (NK) cell surveillance program leading to tumor cell death. The drug combination, but neither agent alone, promotes retinoblastoma (RB) protein-mediated cellular senescence and activation of the immunomodulatory senescence-associated secretory phenotype (SASP). SASP components tumor necrosis factor-α and intercellular adhesion molecule-1 are required for NK cell surveillance of drug-treated tumor cells, which contributes to tumor regressions and prolonged survival in a KRAS-mutant lung cancer mouse model. Therefore, molecularly targeted agents capable of inducing senescence can produce tumor control through non-cell autonomous mechanisms involving NK cell surveillance.
Insights
Combining MAPK and CDK4/6 inhibitors induces senescence and NK cell surveillance, leading to tumor regression in KRAS-mutant lung cancer. This dual action offers a novel therapeutic strategy for lung cancer treatment.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Molecularly targeted therapies are crucial for inhibiting tumor growth.
- KRAS-mutant lung cancer remains a significant therapeutic challenge.
Purpose of the Study:
- To investigate the combined effects of MAPK and CDK4/6 inhibitors on KRAS-mutant lung cancer.
- To elucidate the role of cellular senescence and NK cell surveillance in response to this drug combination.
Main Methods:
- Treatment of KRAS-mutant lung cancer cells with MAPK and CDK4/6 inhibitors.
- Assessment of cellular senescence, SASP activation, and NK cell activity.
- Evaluation of tumor regression and survival in a KRAS-mutant lung cancer mouse model.
Main Results:
- The combination therapy suppressed cancer cell proliferation and induced retinoblastoma protein-mediated senescence.
- Senescence-associated secretory phenotype (SASP) components, TNF-α and ICAM-1, were essential for NK cell-mediated tumor cell killing.
- Combined treatment led to tumor regressions and prolonged survival in vivo.
Conclusions:
- Targeted agents inducing senescence can control tumors via non-cell autonomous NK cell surveillance.
- Combination therapy with MAPK and CDK4/6 inhibitors represents a promising strategy for KRAS-mutant lung cancer.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:25Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
01:27Combined Effects of Drugs: Synergism
Such synergistic combinations...
01:30Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
01:23Binet's Contribution to Measures of Intelligence
01:23Wechsler's Contribution to Measures of Intelligence